As children’s hospitals grapple with intense capacity issues and an increase in patients with respiratory syncytial virus, treatment options are limited. Multiple RSV vaccine candidates are in the works, but the earliest timeline places the first approval next year.
Read the full post on Becker's Hospital Review - Healthcare News
